CORCEPT THERAPEUTICS INC Other Accrued Liabilities, Current
CORCEPT THERAPEUTICS INC (CORT) had Other Accrued Liabilities, Current of $14.75 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-07-29
- 2026-06-30: Other Accrued Liabilities, Current $14.75M.
- 2026-03-31: Other Accrued Liabilities, Current $12.14M.
- 2025-12-31: Other Accrued Liabilities, Current $6.91M.
- 2025-09-30: Other Accrued Liabilities, Current $10.91M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $14.75M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $12.14M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $6.91M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $10.91M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $6.88M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $4.03M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $4.04M 10-K · filed 2026-02-24 | $2.27M 10-K · filed 2025-02-26 |
| 2024-09-30 | $7.30M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $5.30M 10-Q · filed 2024-07-29 | |
| 2024-03-31 | $1.06M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $654.00K 10-K · filed 2025-02-26 | |
| 2023-09-30 | $923.00K 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $638.00K 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $1.22M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $763.00K 10-K · filed 2024-02-15 | $783.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $863.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $623.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $477.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $296.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $518.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $312.00K 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $314.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $202.00K 10-K · filed 2022-02-15 | |
| 2020-09-30 | $249.00K 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $281.00K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $263.00K 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $784.00K 10-K · filed 2021-02-23 | $279.00K 10-K · filed 2020-02-24 |
| 2019-09-30 | $552.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $469.00K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $450.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $386.00K 10-K · filed 2020-02-24 | |
| 2018-09-30 | $264.00K 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $572.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $616.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $496.00K 10-K · filed 2019-02-26 | $562.00K 10-K · filed 2018-02-28 |
| 2017-09-30 | $407.00K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $480.00K 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $469.00K 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $319.00K 10-K · filed 2018-02-28 | |
| 2016-09-30 | $332.00K 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $155.00K 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $126.00K 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $91.00K 10-K · filed 2017-03-06 | |
| 2015-09-30 | $101.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $114.00K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $120.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $31.00K 10-K · filed 2016-03-10 | |
| 2014-09-30 | $63.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $78.00K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $107.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $28.00K 10-K · filed 2015-03-13 | |
| 2013-09-30 | $6.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $85.00K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $35.00K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $116.00K 10-K · filed 2014-03-14 | $109.00K 10-K · filed 2013-03-15 |
| 2012-09-30 | $265.00K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $101.00K 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $37.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |